Malhar Agarwal

Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Francesco Franchi, Fabiana Rollini, Andrea Rivas et al. · Circulation · 2019 · 152 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention

Larisa H. Cavallari, Francesco Franchi, Fabiana Rollini et al. · Journal of Translational Medicine · 2018 · 62 citations · Full text

Medicine, Cardiology, Genetics +17

Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease

Francesco Franchi, Fabiana Rollini, Jose Rivas Rios et al. · Circulation · 2018 · 56 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study

Francesco Franchi, Fabiana Rollini, Emilio Gómez García et al. · Thrombosis and Haemostasis · 2019 · 28 citations

Medicine, Cardiology, Pharmacology +17

Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-Function Genotypes

Francesco Franchi, Fabiana Rollini, José Rivas et al. · JACC Basic to Translational Science · 2020 · 27 citations · Full text

Medicine, Cardiology, Pharmacology +17